Handelsbanken Fonder AB - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 57 filers reported holding AMRYT PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 1.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$7,657
-26.0%
525,178
-62.9%
0.04%
-32.3%
Q4 2022$10,342
-99.9%
1,416,646
+3.0%
0.06%
+1.6%
Q3 2022$9,519,000
-1.0%
1,375,6010.0%0.06%
+3.2%
Q2 2022$9,615,000
-11.5%
1,375,601
+4.6%
0.06%
+1.6%
Q1 2022$10,867,0001,315,6010.06%
Other shareholders
AMRYT PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$64,658,05627.18%
Stonepine Capital Management, LLC 6,333,239$46,232,64519.45%
MPM ASSET MANAGEMENT LLC 2,668,843$19,482,5548.15%
Aquilo Capital Management, LLC 2,098,993$15,322,6495.76%
New Leaf Venture Partners, L.L.C. 449,737$3,283,0802.38%
Global Frontier Investments LLC 505,000$3,6871.62%
Telemetry Investments, L.L.C. 130,262$9511.50%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$46,2351.27%
Rubric Capital Management LP 3,600,000$26,280,0001.15%
Clearline Capital LP 631,942$4,613,1760.82%
View complete list of AMRYT PHARMA PLC shareholders